Drug Delivery News: Breaking Drug Delivery News, Comments and Articles.

AngioScore Announces Completion of Enrollment in Drug-Coated AngioSculpt® Scoring Balloon Catheter First-in-Human Study

AngioScore, Inc., a developer of novel angioplasty catheters for use in the treatment of cardiovascular disease, today announced the completion of enrollment in the Drug-Coated AngioSculpt Scoring Balloon Catheter First-in-Human (FIH) Study (“PATENT-C”). AngioScore anticipates that preliminary data from this study will be available for presentation at...

Protalix Signs Supply Deal with Brazilian Government

Shares of Protalix BioTherapeutics Inc. jumped in premarket trading Wednesday after the drug developer announced a deal that requires the Brazilian government to buy at least $280 million of the company's Gaucher disease treatment. The Israeli compan...

First drug available through myTomorrows

June 6, 2013 - The recently introduced online patient community myTomorrows signed the first agreement for early access to innovative medicines.

Current Progress Towards ANDA Approval of Hydroxyprogesterone Caproate Injection, USP

McGuff Pharmaceuticals, Inc. (MPI) continues to pursue the approval of an Abbreviated New Drug Application (ANDA) for Hydroxyprogesterone Caproate Injection, USP 250mg/mL, 5mL, multiple dose vial; a generic version of Bristol-Myers Squibb’s drug formerly known as Delalutin™. While McGuff Pharmaceuticals can not predict when the FDA will complete its review, MPI remains committed to bringing...

FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv

The US Food and Drug Administration yesterday (June 18) revealed it is investigating two unexplained deaths in patients who received an intramuscular injection of US drug major Eli Lilly's (NYSE: LLY) antipsychotic drug Zyprexa Relprevv (olanzapine p...

NTRR and Partners Explore the Cutting Edge of $1.7 Billion U.S. Medical Marijuana Sector

Neutra Corp. (OTCBB: NTRR), a provider of all-natural wellness solutions, announced today that, alongside new joint venture partner Field of View Technologies, the company is targeting cutting-edge innovations in smokeless delivery of medicinal cannabis in order to capture a share of the growing $1.7 billion U.S. medical marijuana (MMJ) sector....

Dangerous Designer Drugs Dodge Legal System

New designer drugs are creatively manufactured and packaged to skirt drug laws. Designer drug users should seek immediate professional help found at a 24/7 medically supervised detox center such as South Florida's Harbor Village. Miami, Florida (PRWEB) June 19, 2013 According to Vanessa Grigoriadis, a contributing editor of New York Magazine, drug abusers called “psychonauts” are creating...

Santarus/Pharming HAE drug Ruconest under review at FDA

Shares of Santarus rose as high as 4% on 18 June, before closing at $22.28, a gain of 76 cents, or 3.5%.

Demand For DST's Medical Drug Management Service On The Rise As Health Plan Costs Increase

BIRMINGHAM, Ala., June 19, 2013 /PRNewswire/ -- DST Health Solutions, LLC (DSTHS), a leading provider of technology solutions and services to health plans, integrated delivery systems, and health care providers, has announced that demand for its Medical Drug Management Service (MDMS) has jumped significantly. A customizable solution used to clinically edit and automate the pricing of medical pres...

New BD Biosciences Flow Cytometry Cell Analyzer Enables Complex Multicolor Experiments in Disease Research

SAN JOSE, Calif., June 19, 2013 /PRNewswire/ -- BD Biosciences, a segment of BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the launch of the BD LSRFortessa™ X-20 Cell Analyzer, the latest in its line of high-performance research flow cytometers. The BD LSRFortessa X-20 Cell Analyzer delivers high-performance multicolor analysis...

Belrose Pharma Acquires Enzon's Advanced Drug Formulation Technology and Clinical Assets as Foundation for Driving Development of More Effective Injectable and Sustained Release Therapies

PRINCETON, N.J., June 19, 2013 /PRNewswire-iReach/ -- In its first major deal, Belrose Pharma, a new specialty pharmaceutical company dedicated to advancing development of the next generation of innovative injectable and sustained release drug therapies in patient disease populations with high unmet medical needs, today announced the acquisition of Enzon Pharmaceutical's PEGylation Linker Technolo...

NeuroDerm Announces Presentation of Data from Studies Evaluating ND0612, an Investigational Levodopa Continuous Administration Drug, in Healthy Volunteers and in Patients with Advanced Parkinson's Disease

NESS ZIONA, Israel, June 19, 2013 /PRNewswire/ -- NeuroDerm, Ltd. today announced that results from a phase I study in volunteers, and preliminary results from a phase IIA study in advanced Parkinson's patients, of ND0612, were presented at the 2013 International Congress of Parkinson's Disease and Movement Disorders. ND0612 is a proprietary levodopa/carbidopa liquid drug formula under developmen...

Omnicell Named Top Vendor in 2013 KLAS Pharmacy Automation Equipment Rankings

MOUNTAIN VIEW, Calif., June 19, 2013 /PRNewswire/ -- Omnicell, Inc. (NASDAQ: OMCL) a leading provider of medication and supply management solutions and analytics software for healthcare facilities, today announced that it was named the number one overall pharmacy equipment vendor in the KLAS 2013 Medical Equipment & Infrastructure Report. KLAS, a leading independent healthcare research fi...

GVK BIO and US FDA Announce Drug Repositioning Collaboration - License to GVK BIO SAR Database GOSTAR

GVK Biosciences (GVK BIO) today announced that it has licensed its popular SAR, PK and Toxicity Database (GOSTAR) to the US Food and Drug Administration (USFDA). The Material Transfer Agreement forms the basis of collaboration in Drug Repositioning, wherein the initial focus will be to identify alternative therapeutic indications of marketed compounds...

eClinical Provider DATATRAK joins SAS® Alliance to Offer Cloud-Based SAS® Drug Development

CLEVELAND, June 19, 2013 /PRNewswire/ -- DATATRAK International, Inc. (OTCQX: DTRK), a leader in developing cloud-based, unified eClinical® technologies and delivering related services for the clinical trials industry, today announced their partnership with SAS to provide SAS® Drug Development as an extension of the DATATRAK ONE™ solution. (Logo: http://photos.prnewswire.com...

AstraZeneca, Bristol diabetes drug disappoints in key test

LONDON (Reuters) - AstraZeneca and Bristol-Myers Squibb's diabetes drug Onglyza failed to reduce heart risks in a large clinical study, disappointing investors who had thought it might demonstrate an edge over rivals.

Pharmacies and Drug Retailers in China Industry Research Report – Now Available from IBISWorld

Over the past five years, revenue for the Pharmacy and Drug Retailer industry has been growing at an annualized rate of 9.5% to an expected $42.7 billion in 2013. The government's support for the development of chain drug retailing enterprises has also been a positive influence on the industry. San Francisco, CA (PRWEB) June 19, 2013 Over the past five years, revenue for the Pharmacy and Drug...

Express Diagnostics’ DrugCheck® On-site Test Cup Receives Health Canada Class III Medical Device Approval

Express Diagnostics Int’l today announced that it has received Health Canada Class III approval to market and sell its DrugCheck® NxStep Onsite Drug Screen Cup in Canada. The urinalysis screening device received Class III approval for 24 different drugs and detection levels, including cotinine (nicotine), EDDP, K2/spice (synthetic marijuana), ketamine, and alcohol. Blue Earth, MN (PRWEB) Ju...

Corporate Whistle Blower Center Now Urges Drug Maker Insiders to Call Them About Substantial Rewards if They Can Prove Off Labeling, Kickback or Price Fixing Schemes

The Corporate Whistle Blower Center is urging drug maker industry insiders, or medical doctors to call them if they possess significant proof, a drug maker, or a pharmaceutical wholesaler is knowingly, and intentionally cheating the US taxpayer supported Medicare with off labeling schemes, kickbacks, and price fixing schemes, because the rewards could be in the millions of dollars. For more inform...

Pensacola, Florida Joins Best Halfway House Recovery Network, Providing Resources for Those Seeking to Further Their Recovery from Drug and Alcohol Addiction

Best Halfway House, a sober resource network that provides housing resources for those who have completed drug and alcohol addiction treatment, is extending its services into the Pensacola, Florida area. West Palm Beach, FL (PRWEB) June 19, 2013 Best Halfway House is stretching its sober housing network into the Pensacola area, giving people a chance to keep on their road of recovery from drug an...

Crystal Meth Addiction Treatment and Crystal Meth Drug Rehab Announced by Recovery Associates

Crystal meth is a stimulant named for the structure that is formed while being made. Recovery Associates delivers multiple tracks of drug rehab treatment for people seeking recovery from crystal meth usage. WEST PALM BEACH, Florida (PRWEB) June 19, 2013 Recovery Associates, through its multiple therapeutic tracks, is placing an emphasis upon crystal meth addiction treatment, helping men and women...

US Drug Watchdog Now Urges Recipients Of A DePuy Pinnacle All Metal Hip Implant To Call Them About A Vital Blood Test To See If Their Hip Implant Device Has Failed

The US Drug Watchdog says, "The reason there is ongoing national litigation involving the DePuy Pinnacle metal on metal hip implant is premature failure issues, and we think the easiest way for a recipient to discover is this type of metal on metal hip implant has failed is to get a very simple blood test to see if they have elevated levels of cobalt, and chromium in their blood stream, and r...

Best Drug Rehabilitation CEO Per Wickstrom Interviews Cathy Rigby on America’s Drug Abuse Epidemic

Per Wickstrom, the CEO of holistic treatment facilities including Best Drug Rehabilitation, recently interviewed speaker, actress and former gymnast Cathy Rigby at the Imagination Heals event in Los Angeles. (PRWEB) June 19, 2013 Best Drug Rehabilitation’s CEO Per Wickstrom, a leading advocate of treatment that involves extensive one-on-one counselling with an experienced, compassionate and lic...

Perispinally Administered Enbrel Facilitates Rapid Recovery of Cognitive Function in Patients with Alzheimer's

Newly published research by the prestigious Dana Foundation elucidates the operational mechanisms enabling the restoration of mental faculties. NWC physicians applaud the Dana Foundation's contribution to understanding the role neuro-inflammation plays in the pathogenesis of Alzheimer's disease. (PRWEB) June 19, 2013 Pharmaceutical history is replete with examples of drugs being utilized...

St Jude Retreats Announces New Line of Promotional Awareness Videos

The St Jude Retreats will launch a series of new videos covering various topics from drug and alcohol awareness, to information on getting help for addiction. New York (PRWEB) June 19, 2013 The St Jude Program is proud to announce a new line of promotional and originally created videos to be produced and launched through the rest of 2013 and throughout 2014. These dynamic videos will put a spin o...